Massachusetts-based Moderna will likely be the first to manufacture a bird flu vaccine, backed by hundreds of millions in government funding. The biopharmaceutical giant is developing the vaccine as a ...
Moderna is the only company in its peer group burning cash at an alarming rate. Click here to read more about MRNA stock and ...
We recently compiled a list of the 12 Best S&P 500 Stocks to Invest in According to Analysts. In this article, we are going ...
Moderna is set to receive $590m in funding from the HHS to expedite the development of mRNA-based pandemic influenza vaccines ...
The US Department of HHS is awarding the pharmaceutical company Moderna $590 million to continue developing a vaccine to protect against bird flu.
The government wants Moderna to push forward with various bird flu vaccines as well as mRNA shots for other influenza strains ...
Chairman Larry Ellison highlighted the AI's potential in the development of mRNA-based cancer vaccines. Read more here.
“mRNA technology will complement existing vaccine technology, allowing us to move faster and better target emerging viruses to protect Americans against future pandemics.” Last year, Moderna ...
Discover how scientists developed a COVID-19 vaccine in record time using mRNA technology, leading to improved public health ...
Moderna Inc (NASDAQ:MRNA) shares are trading lower Wednesday after Goldman Sachs downgraded the stock. Here's what you need ...
In a report released yesterday, Courtney Breen from Bernstein maintained a Hold rating on Moderna (MRNA – Research Report), with a price target ...
The Agreement provides participating countries with the opportunity to diversify their mRNA COVID-19 vaccine supply and gain ...